Even though the MET RTK is not included in the list of oncogenic RTKs pathway genes, we included MET in our study because deregulated MET signaling promotes HCC, and SOCS1 and SOCS3 are known to regulate MET kinase activity [23, 26, 27]. Here, MET is linked to hepatocellular carcinoma.